101 results
Page 2 of 6
8-K
qtg81 z4v2gg29h
22 May 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:07pm
8-K
EX-99.1
5m17fra
12 May 23
Avenue Therapeutics Reports First Quarter 2023 Financial Results and Recent Corporate Highlights
8:35am
8-K
EX-99.1
0tj stije9niq4ae9
17 Apr 23
Avenue Therapeutics Announces Regulatory Update Based on Type C Meeting with FDA and Next Steps in the Development of IV Tramadol
4:06pm
8-K
EX-99.1
j13h wl89cfphyl5
30 Mar 23
Avenue Therapeutics Reports Full Year 2022 Financial Results and Recent Corporate Highlights
4:07pm
8-K
EX-99.1
uqxdd4 kf
10 Nov 22
Avenue Therapeutics Reports Third Quarter 2022 Financial Results and Recent Corporate Highlights
4:29pm
8-K
EX-99.1
b8xvplfy h7
8 Nov 22
Completion of Acquisition or Disposition of Assets
8:40am
8-K
EX-99.2
481vxgwyz o4s83o
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
8-K
EX-99.1
jr3kf
12 Oct 22
Avenue Therapeutics Announces Pricing of $12 Million Underwritten Public Offering
9:00am
424B4
06cug37
11 Oct 22
Prospectus supplement with pricing info
8:27am
FWP
zccvve9ynw ytae
6 Oct 22
Free writing prospectus
4:05pm
8-K
EX-99.1
1qpy1tgkqcxej 3s8h
22 Sep 22
Material Modifications to Rights of Security Holders
4:32pm